Cell and Gene Therapy Trials: Are We Facing an ‘Evidence Crisis’?
Open Access
- 1 January 2019
- journal article
- editorial
- Published by Elsevier in eClinicalMedicine
- Vol. 7, 13-14
- https://doi.org/10.1016/j.eclinm.2019.01.015
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Enhancing patient-level clinical data access to promote evidence-based practice and incentivize therapeutic innovationAdvanced Drug Delivery Reviews, 2018
- Registry Contributions to Strengthen Cell and Gene Therapeutic EvidenceMolecular Therapy, 2018
- Barriers to the conduct of randomised clinical trials within all disease areasTrials, 2017
- Overcoming Challenges Facing Advanced Therapies in the EU MarketCell Stem Cell, 2016
- What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and productsSystematic Reviews, 2016
- Diversity in Clinical and Biomedical Research: A Promise Yet to Be FulfilledPLoS Medicine, 2015
- Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012JAMA, 2014